Skip to content
Biodatica
Start free

Investigator

Laura G. Schuettpelz

WASHINGTON UNIVERSITY · funded by NIAID, NCI, NHLBI

Companies
1

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$1.6M

Summed across those awards.

First award
Sep 3, 2013

Latest Jun 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • Akeso

    OncologyPhase IListed · 9926.HK

    82momentum

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Modeling TLR8 Gain of Function Disease

    $233k

    Jun 1, 2026NIAIDWASHINGTON UNIVERSITYNIH RePORTER · 11350215 (opens the source filing in a new tab)

  2. R01

    Defining the partner interaction network of the tetraspanin CD53 in regulating B cell trafficking

    $563k

    Jul 6, 2022NIAIDWASHINGTON UNIVERSITYNIH RePORTER · 11116852 (opens the source filing in a new tab)

  3. T32

    Pediatric Training Program Hematology and Oncology

    $156k

    Apr 1, 2022NCIWASHINGTON UNIVERSITYNIH RePORTER · 11045065 (opens the source filing in a new tab)

  4. T32

    Pediatric Training Program Hematology and Oncology

    $116k

    Apr 1, 2022NCIWASHINGTON UNIVERSITYNIH RePORTER · 11322002 (opens the source filing in a new tab)

  5. R01

    Protection of stressed hematopoietic stem cells by the tetraspanin family member CD53

    $389k

    Jan 1, 2017NHLBIWASHINGTON UNIVERSITYNIH RePORTER · 11249213 (opens the source filing in a new tab)

  6. P50

    Developmental Research Program

    $129k

    Sep 3, 2013NCIWASHINGTON UNIVERSITYNIH RePORTER · 11195620 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources